An oral care self-management support protocol (OrCaSS) to reduce oral mucositis in hospitalized patients with acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation: a randomized controlled pilot study
- First Online:
Oral mucositis (OM) is a common and debilitating side effect of chemoradiotherapy in patients awaiting allogeneic hematopoietic stem cell transplantation (aHSCT).
The aim of this pilot RCT was to compare an oral care self-management support protocol (OrCaSS) to usual pre-aHSCT care. Feasibility was tested, effect sizes calculated for OM (primary outcome), and patient adherence was measured (secondary outcome).
Eighteen AML patients awaiting aHSCT and hospitalized between August 2012 and April 2013 were randomized 1:1 to usual care (UCG) and intervention (IG) groups. The OrCaSS protocol consisted of two sessions of educational and behavioral interventions, the first delivered 1 week pre-admission (T1), the second on admission day (T2). Via field notes, practicability and acceptability were evaluated to explore the feasibility of intervention and study procedures. OM data were collected at T1, T2, and daily for 28 days using the WHO scale. The effect size r was calculated (r less than −0.1 ≙ small and greater than or equal to −0.3 ≙ medium). Patients’ adherence to the protocol was assessed at T1, T2, and 8–10 days post-HSCT (T3).
Research and intervention procedures were feasible. OM incidence was 100 %. The IG’s median highest OM grade was 2.0 (IQR = 2); the UCGs was 3.0 (IQR = 2; r = −0.1). Median OM durations were 12 days in the IG and 14 days in the UCG (r = −0.1). OM onset was 2 days later in the IG than in the UCG (r = −0.1). Over the course of the study, patient adherence decreased in both groups.
OrCaSS is a promising intervention to delay and reduce OM. These results can serve to plan a larger RCT.
KeywordsOral mucositis Oral care protocol Allogeneic stem cell transplantation
- 2.Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury—pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9):1995–2025. doi:10.1002/cncr.20162 PubMedCrossRefGoogle Scholar
- 3.Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, Costazza G, Mega A, Matozzo V, Berni M, Alberani F, Banfi MM, Martinelli L, Munaron S, Orlando L, Lubiato L, Leanza S, Guerrato R, Rossetti A, Messina M, Barzetti L, Satta G, Dimonte V (2011) Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplant 46(5):727–732. doi:10.1038/bmt.2010.184 PubMedCrossRefGoogle Scholar
- 6.Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FKL, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205PubMedGoogle Scholar
- 9.Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, McCabe MG, Meyer S, Khalid T (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (4):CD000978. doi:10.1002/14651858.CD000978.pub5
- 10.Peterson DE, Öhrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S (2012) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 1-6Google Scholar
- 12.Stone R, Quinn B, McCann S, Blijlevens N (2006) Improving oral care in transplantation: quality control of oral mucositis, assessment in the EBMT Prospective Oral Mucositis Audit (POMA). Bone Marrow Transplant 37:S270–S271Google Scholar
- 15.Yamagata K, Arai C, Sasaki H, Takeuchi Y, Onizawa K, Yanagawa T, Ishibashi N, Karube R, Shinozuka K, Hasegawa Y, Chiba S, Bukawa H (2012) The effect of oral management on the severity of oral mucositis during hematopoietic SCT. Bone Marrow Transplant 47(5):725–730. doi:10.1038/bmt.2011.171 PubMedCrossRefGoogle Scholar
- 17.Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, Kanehira T, Yamamoto S, Kondo T, Endo T, Tanaka J, Hashino S, Nishio M, Imamura M, Kitagawa Y, Inoue N (2012) Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer 20(2):367–373. doi:10.1007/s00520-011-1116-x PubMedCrossRefGoogle Scholar
- 20.Antunes HS, Ferreira EMD, de Faria LMD, Schirmer M, Rodrigues PC, Small IA, Colares M, Bouzas LFD, Ferreira CG (2010) Streptococcal bacteremia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine. Med Oral Patol Oral Cir Bucal 15(2):E303–E309. doi:10.4317/Medoral.15.E303, Artn 2689 PubMedCrossRefGoogle Scholar
- 24.Stiff PJ, Erder H, Bensinger WI, Emmanouilides C, Gentile T, Isitt J, Lu ZJ, Spielberger R (2006) Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37(4):393–401. doi:10.1038/sj.bmt.1705250 PubMedCrossRefGoogle Scholar
- 27.Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, Eccles MP, Cane J, Wood CE (2013) The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 46(1):81–95. doi:10.1007/s12160-013-9486-6 PubMedCrossRefGoogle Scholar
- 28.World Health Organization (1979) WHO (World Health Organization, Genf) Handbook for reporting results of cancer treatment. WHOGoogle Scholar
- 29.Dobbels F, Berben L, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C (2010) The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation 90(2):205–219PubMedCrossRefGoogle Scholar
- 30.de Marsicano E, da Fernandes N, Colugnati F, Grincenkov FR, Fernandes NM, De Geest S, Sanders-Pinheiro H (2013) Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol 14(1):108PubMedCentralCrossRefGoogle Scholar
- 33.Leuven-Basel Adherence Research Group (2005) The Basel Assessment of Adherence with Immunosuppressive Medication Scale (BAASIS©). BelgiumGoogle Scholar
- 34.Rosenthal R (1991) Meta-analytic procedures for social research, vol 6. SAGE Publications, IncorporatedGoogle Scholar
- 36.Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and Bone-Marrow Transplantation—a randomized controlled trial comparing 2 protocols of dental-care. Eur J Cancer B Oral Oncol 30B(2):93–97PubMedCrossRefGoogle Scholar
- 40.Odeh B, Kayyali R, Nabhani-Gebara S, Philip N (2015) Optimizing cancer care through mobile health. Support Care Cancer 1-6Google Scholar